Preparation of Engineered Salmonella Typhimurium-Driven Hyaluronic-Acid-Based Microbeads with Both Chemotactic and Biological Targeting Towards Breast Cancer Cells for Enhanced Anticancer Therapy

Advanced Healthcare Materials

Volumn 5, Issue 2, 2016, Pages 288-295

  Uthaman, Saji ^a   Zheng, Shaohui ^b   Han, Jiwon ^b   Choi, Young Jin ^b   Cho, Sunghoon ^b   Nguyen, Van Du ^b   Park, Jong Oh ^b   Park, Seung Hwan ^a   Min, Jung Joon ^a   Park, Sukho ^b   Park, In Kyu ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Bacteriobots; CD 44 receptor; Dual tumor targeting; Hyaluronic acid; Salmonella typhimurium

Indexed keywords

CELLS; CONTROLLED DRUG DELIVERY; CROSSLINKING; CYTOLOGY; DRUG PRODUCTS; MICROBEADS; ORGANIC ACIDS; SALMONELLA; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; TUMORS;

ANTI-CANCER THERAPIES; BACTERIOBOTS; CD 44 RECEPTOR; FLOW CYTOMETRY ANALYSIS; INTRACELLULAR UPTAKE; MICHAEL-TYPE ADDITIONS; SALMONELLA TYPHIMURIUM; TUMOR TARGETING;

HYALURONIC ACID;

DOCETAXEL; DRUG CARRIER; HERMES ANTIGEN; MACROGOL; NANOPARTICLE; SALMONELLA TYPHIMURIUM DRIVEN HYALURONIC ACID BASED MICROBEAD BACTERIOBOT; STREPTAVIDIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; HYALURONIC ACID; LACTIC ACID; MALEIMIDE DERIVATIVE; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TAXOID;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM ADHERENCE; BREAST CANCER CELL LINE; CELL TRANSPORT; CELL VIABILITY; CHEMOTAXIS; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; FLOW CYTOMETRY; GENETIC ENGINEERING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MICROFLUIDICS; MOLECULAR INTERACTION; MOLECULARLY TARGETED THERAPY; NANOENCAPSULATION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE PROPERTY; SYNTHESIS; 3T3 CELL LINE; ANIMAL; BREAST NEOPLASMS; CELL DEATH; CHEMISTRY; DRUG EFFECTS; ENDOCYTOSIS; FEMALE; METABOLISM; MOUSE; MOVEMENT (PHYSIOLOGY); PATHOLOGY; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CHEMOTAXIS; DRUG LIBERATION; ENDOCYTOSIS; FEMALE; FLOW CYTOMETRY; GENETIC ENGINEERING; HYALURONIC ACID; LACTIC ACID; MALEIMIDES; MICE; MICROSPHERES; MOVEMENT; NANOPARTICLES; NIH 3T3 CELLS; POLYGLYCOLIC ACID; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SALMONELLA TYPHIMURIUM; TAXOIDS;

EID: 84956736491     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201500556     Document Type: Article

References (30)

1. R. L. Siegel, K. D. Miller, A. Jemal, CA: A Cancer J. Clin. 2015, 65, 5.
2. R. K. Jain, T. Stylianopoulos, Nat. Rev. Clin. Oncol. 2010, 7, 653.
3. O. Trédan, C. M. Galmarini, K. Patel, I. F. Tannock, J. Natl. Cancer Inst. 2007, 99, 1441.
4. S. Uthaman, S. Maya, R. Jayakumar, C. S. Cho, I. K. Park, J. Nanosci. Nanotechnol. 2014, 14, 694.
5. E. N. Harris, J. A. Weigel, P. H. Weigel, J. Biol. Chem. 2008, 283, 17341.
6. R. Prevo, S. Banerji, D. J. P. Ferguson, S. Clasper, D. G. Jackson, J. Biol. Chem. 2001, 276, 19420.
7. A. Aruffo, I. Stamenkovic, M. Melnick, C. B. Underhill, B. Seed, Cell 1990, 61, 1303.
8. J. Entwistle, C. L. Hall, E. A. Turley, J. Cell Biochem. 1996, 61, 569.
9. Y. Takei, A. Maruyama, A. Ferdous, Y. Nishimura, S. Kawano, K. Ikejima, S. Okumura, S. Asayama, M. Nogawa, M. Hashimoto, Y. Makino, M. Kinoshita, S. Watanabe, T. Akaike, J. J. Lemasters, N. Sato, FASEB J. 2004, 18, 699.
10. K. S. Kim, W. Hur, S. J. Park, S. W. Hong, J. E. Choi, E. J. Goh, S. K. Yoon, S. K. Hahn, ACS Nano 2010, 4, 3005.
11. H. Yin, F. Zhao, D. H. Zhang, J. Li, Int. J. Pharm. 2015, 483, 169
12. X. Y. Cao, L. Tao, S. H. Wen, W. X. Hou, X. Y. Shi, Carbohydr. Res. 2015, 405, 70.
13. V. J. Wielenga, K.-H. Heider, G. Johan, A. Offerhaus, G. R. Adolf, F. M. van den Berg, H. Ponta, P. Herrlich, S. T. Pals, Cancer Res. 1993, 53, 4754.
14. H. Y. Yoon, H. Koo, K. Y. Choi, S. J. Lee, K. Kim, I. C. Kwon, J. F. Leary, K. Park, S. H. Yuk, J. H. Park, Biomaterials 2012, 33, 3980.
15. M. S. Rajput, P. Agrawal, Indian J. Cancer 2010, 47, 458.
16. M. C. Burgmans, Y. H. Kao, F. G. Irani, E. L. Dames, T. K. B. Teo, A. S. W. Goh, P. K. H. Chow, K. H. Tay, R. H. G. Lo, J. Vasc. Interv. Radiol. 2012, 23, 1294.
17. S. J. Park, S. H. Park, S. Cho, D. M. Kim, Y. Lee, S. Y. Ko, Y. Hong, H. E. Choy, J. J. Min, J. O. Park, S. Park, Sci. Rep.-UK 2013, 3.
18. U. N. Le, H. S. Kim, J. S. Kwon, M. Y. Kim, V. H. Nguyen, S. N. Jiang, B. I. Lee, Y. Hong, M. G. Shin, J. H. Rhee, H. S. Bom, Y. Ahn, S. S. Gambhir, H. E. Choy, J. J. Min, Mol. Ther. 2011, 19, 951.
19. S. Cho, S. J. Park, S. Y. Ko, J. O. Park, S. Park, Biomed. Microdevices 2012, 14, 1019.
20. S. J. Park, Y. K. Lee, S. Cho, S. Uthaman, I. K. Park, J. J. Min, S. Y. Ko, J. O. Park, S. Park, Biotechnol. Bioeng. 2015, 112, 769.
21. M. Kojima, Z. H. Zhang, M. Nakajima, T. Fukuda, Biomed. Microdevices 2012, 14, 1027.
22. R. Mhanna, F. M. Qiu, L. Zhang, Y. Ding, K. Sugihara, M. Zenobi-Wong, B. J. Nelson, Small 2014, 10, 1953.
23. V. Magdanz, S. Sanchez, O. G. Schmidt, Adv. Mater. 2013, 25, 6581.
24. P. L. Venugopalan, R. Sai, Y. Chandorkar, B. Basu, S. Shivashankar, A. Ghosh, Nano Lett. 2014, 14, 1968.
25. P. Burgos, M. Geoghegan, G. J. Leggett, Nano Lett. 2007, 7, 3747.
26. R. Jin, P. J. Dijkstra, J. Feijen, J. Controlled Release 2010, 148, e41.
27. A. Anitha, S. Uthaman, S. V. Nair, R. Jayakumar, V. K. Lakshmanan, J. Biomed. Nanotechnol. 2013, 9, 335.
28. V. H. Nguyen, H. S. Kim, J. M. Ha, Y. J. Hong, H. E. Choy, J. J. Min, Cancer Res. 2010, 70, 18.
29. Z. Xu, W. Gu, J. Huang, H. Sui, Z. Zhou, Y. Yang, Z. Yan, Y. Li, Int. J. Pharm. 2005, 288, 361.
30. Y. Xia, G. M. Whitesides, Annu. Rev. Mater. Sci. 1998, 28, 153.